These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30699275)

  • 1. Prevention and control of neoplasms associated with HPV in high-risk groups in Mexico City: The Condesa Study.
    Lazcano-Ponce E; Salmerón J; González A; Allen-Leigh B; León-Maldonado L; Magis C; Aranda-Flores C; Conde-González C; Portillo-Romero AJ; Yunes-Díaz E; Rivera-Rivera L; Vargas G; Nyitray AG; Giuliano AR
    Salud Publica Mex; 2018; 60(6):703-712. PubMed ID: 30699275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of human papillomavirus (HPV)-related tumors in people living with human immunodeficiency virus (HIV).
    Poljak M; Šterbenc A; Lunar MM
    Expert Rev Anti Infect Ther; 2017 Nov; 15(11):987-999. PubMed ID: 29027811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anal intraepithelial neoplasia in a multisite study of HIV-infected and high-risk HIV-uninfected women.
    Hessol NA; Holly EA; Efird JT; Minkoff H; Schowalter K; Darragh TM; Burk RD; Strickler HD; Greenblatt RM; Palefsky JM
    AIDS; 2009 Jan; 23(1):59-70. PubMed ID: 19050387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus-related disease in people with HIV.
    Palefsky J
    Curr Opin HIV AIDS; 2009 Jan; 4(1):52-6. PubMed ID: 19339939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening and prevention of HPV-related anogenital cancers in women living with HIV in Europe: Results from a systematic review.
    Krankowska D; Mazzitelli M; Ucak HA; Orviz E; Karakoc HN; Mortimer H; Aebi-Popp K; Gilleece Y
    HIV Med; 2024 Jul; 25(7):769-793. PubMed ID: 38238990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions.
    Serrano B; de Sanjosé S; Tous S; Quiros B; Muñoz N; Bosch X; Alemany L
    Eur J Cancer; 2015 Sep; 51(13):1732-41. PubMed ID: 26121913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Prevalence of Anal High-Grade Squamous Intraepithelial Lesions, and Prevention Through Human Papillomavirus Vaccination, in Young Men Who Have Sex With Men Living With Human Immunodeficiency Virus.
    Palefsky JM; Lensing SY; Belzer M; Lee J; Gaur AH; Mayer K; Futterman D; Stier EA; Paul ME; Chiao EY; Reirden D; Goldstone SE; Tirado M; Cachay ER; Barroso LF; Da Costa M; Darragh TM; Rudy BJ; Wilson CM; Kahn JA
    Clin Infect Dis; 2021 Oct; 73(8):1388-1396. PubMed ID: 33991185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancers attributable to human papillomavirus infection.
    Grulich AE; Jin F; Conway EL; Stein AN; Hocking J
    Sex Health; 2010 Sep; 7(3):244-52. PubMed ID: 20719211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of sex-neutral HPV-vaccination in Sweden, accounting for herd-immunity and sexual behaviour.
    Wolff E; Elfström KM; Haugen Cange H; Larsson S; Englund H; Sparén P; Roth A
    Vaccine; 2018 Aug; 36(34):5160-5165. PubMed ID: 30017146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Papillomavirus in Kidney Transplant Recipients.
    Chin-Hong PV
    Semin Nephrol; 2016 Sep; 36(5):397-404. PubMed ID: 27772624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease.
    Arbyn M; de Sanjosé S; Saraiya M; Sideri M; Palefsky J; Lacey C; Gillison M; Bruni L; Ronco G; Wentzensen N; Brotherton J; Qiao YL; Denny L; Bornstein J; Abramowitz L; Giuliano A; Tommasino M; Monsonego J
    Int J Cancer; 2012 Nov; 131(9):1969-82. PubMed ID: 22623137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EBCOG position statement: Gender neutral HPV vaccination for young adults.
    Verheijen RHM; Mahmood T; Donders G; Redman CWE; Wood P
    Eur J Obstet Gynecol Reprod Biol; 2020 Mar; 246():187-189. PubMed ID: 31992466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health utilities lost and risk factors associated with HPV-induced diseases in men and women: the HPV Italian collaborative study group.
    Marcellusi A; Capone A; Favato G; Mennini FS; Baio G; Haeussler K; Bononi M;
    Clin Ther; 2015 Jan; 37(1):156-167.e4. PubMed ID: 25487083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of HPV vaccination against the development of high-grade cervical lesions in young Japanese women.
    Shiko Y; Konno R; Konishi H; Sauvaget C; Ohashi Y; Kakizoe T
    BMC Infect Dis; 2020 Nov; 20(1):808. PubMed ID: 33153446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus genotype attribution and estimation of preventable fraction of anal intraepithelial neoplasia cases among HIV-infected men who have sex with men.
    Sahasrabuddhe VV; Castle PE; Follansbee S; Borgonovo S; Tokugawa D; Schwartz LM; Lorey TS; LaMere BJ; Gage JC; Fetterman B; Boyle S; Sadorra M; Tang SD; Darragh TM; Wentzensen N
    J Infect Dis; 2013 Feb; 207(3):392-401. PubMed ID: 23162133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency of HPV genotypes 59, 66, 52, 51, 39 and 56 in women from Western Mexico.
    Molina-Pineda A; López-Cardona MG; Limón-Toledo LP; Cantón-Romero JC; Martínez-Silva MG; Ramos-Sánchez HV; Flores-Miramontes MG; de la Mata-González P; Jave-Suárez LF; Aguilar-Lemarroy A
    BMC Infect Dis; 2020 Nov; 20(1):889. PubMed ID: 33238902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.
    Muñoz N; Kjaer SK; Sigurdsson K; Iversen OE; Hernandez-Avila M; Wheeler CM; Perez G; Brown DR; Koutsky LA; Tay EH; Garcia PJ; Ault KA; Garland SM; Leodolter S; Olsson SE; Tang GW; Ferris DG; Paavonen J; Steben M; Bosch FX; Dillner J; Huh WK; Joura EA; Kurman RJ; Majewski S; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan JT; Lupinacci LC; Giacoletti KE; Sings HL; James MK; Hesley TM; Barr E; Haupt RM
    J Natl Cancer Inst; 2010 Mar; 102(5):325-39. PubMed ID: 20139221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of HPV vaccination in the context of high cervical cancer incidence and low screening coverage.
    Võrno T; Lutsar K; Uusküla A; Padrik L; Raud T; Reile R; Nahkur O; Kiivet RA
    Vaccine; 2017 Nov; 35(46):6329-6335. PubMed ID: 28899625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus vaccines and anal carcinoma.
    Franceschi S; De Vuyst H
    Curr Opin HIV AIDS; 2009 Jan; 4(1):57-63. PubMed ID: 19339940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive control of human papillomavirus infections and related diseases.
    Bosch FX; Broker TR; Forman D; Moscicki AB; Gillison ML; Doorbar J; Stern PL; Stanley M; Arbyn M; Poljak M; Cuzick J; Castle PE; Schiller JT; Markowitz LE; Fisher WA; Canfell K; Denny LA; Franco EL; Steben M; Kane MA; Schiffman M; Meijer CJ; Sankaranarayanan R; Castellsagué X; Kim JJ; Brotons M; Alemany L; Albero G; Diaz M; de Sanjosé S;
    Vaccine; 2013 Dec; 31 Suppl 5():F1-31. PubMed ID: 24331745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.